|
|
Post by blindhog1 on Nov 6, 2015 3:47:49 GMT -5
This Sanofi chart alone in this presentation will quite the rumor mill about MNKD and SNY. This should increase PPS tomorrow. 
OK no chart. See hd99 on the last page.
|
|
|
|
Post by benyiju on Nov 6, 2015 3:49:12 GMT -5
Don't be typical American hamburger-eating surrender monkeys! Let Sanofi do their thing, they know their business better than Mankind amateurs.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Nov 6, 2015 3:51:14 GMT -5
I suspect you might be correct. Tomorrow could be good. Sanofi isn't going anywhere.
|
|
|
|
Post by benyiju on Nov 6, 2015 3:53:49 GMT -5
That's the spirit! Let's all chant "I believe that we will win!"
|
|
|
|
Post by benyiju on Nov 6, 2015 3:55:22 GMT -5
Where's Kastanes? In this dark hour we need our cheerleaders!
|
|
|
|
Post by benyiju on Nov 6, 2015 3:57:50 GMT -5
Je crois que nous allons gagner!
|
|
|
|
Post by jpg on Nov 6, 2015 3:58:31 GMT -5
It's rather obvious Afrezza is part of the B team from now on (which isn't any different than it was really). The low key launch should continue and hopefully we will gain some traction. The change in CEO is obviously what did us in.
Mannkind is jinxed it seems.
|
|
taco
Newbie
Posts: 2 
|
Post by taco on Nov 6, 2015 3:59:56 GMT -5
|
|
|
|
Post by doodyfree on Nov 6, 2015 4:06:31 GMT -5
We're still in the family. If scripts pick up, we'll get more attention. I'm fine with waiting it out, don't have a choice really.
|
|
|
|
Post by whanley7 on Nov 6, 2015 4:08:13 GMT -5
I may be reaching for anything I can grab here... Forgive me the stock price has done that to the best of us recently... But the Google Life Sciences slide is right after the Afrezza slide in their presentation. Does that mean anything?
|
|
|
|
Post by benyiju on Nov 6, 2015 4:11:49 GMT -5
Bon courage à toute l'équipe de Mannkind dans ces circonstances vraiment difficiles !
|
|
|
|
Post by benyiju on Nov 6, 2015 4:14:22 GMT -5
Notre contribution consiste simplement à Sanofi souhaiter bon courage comme organisation plus légère, plus flexible, plus audacieuse!
|
|
|
|
Post by mnkdnut on Nov 6, 2015 4:15:03 GMT -5
To not even be listed on slide 104 (Important Options for Prandial Diabetes Treatment) kinds tells you our position on the totem pole. On the other hand, having slide 105 at least tells the shorts we're not being kicked off of the totem pole (IMO). Besides having incredible bad luck with the CEO turnover, not having a robust clinical outcomes study is seriously holding us back.
|
|
|
|
Post by EveningOfTheDay on Nov 6, 2015 4:26:10 GMT -5
So is this punishment for nor accepting an previous offer? Is this Sanofi being pragmatic? Are we part of just a bunch of stuff they are throwing at the wall to see what sticks?
So they are not dropping us, obviously, which made no sense to me, but we get no break. Suffering goes on and now we all really need to reassess our deepest believes... or at least I think I will.
|
|
|
|
Post by jpg on Nov 6, 2015 4:26:56 GMT -5
Having just 10% penetration in 1.1 million target patients would be more than enough to get us going and get people to notice Afrezza.
I give this CC a C- (compared to what I was expecting it is actually better!).
And I changed my Avatar for good luck or to sail away!
|
|
